“BATF/RORgt/IL-17 Axis as a Therapeutic Target in Systemic Lupus Erythematosus: Integrative Bioinformatics and In Vivo Validation of Langchuangding Combined with Prednisone”, ACTA, vol. 89, Jun. 2026, Accessed: Oct. 06, 2026. [Online]. Available: https://actabe.net/index.php/ACTA/article/view/58